Sign in
4

Changes in Ownership

OptimizeRx Corp Filed Acc 0001628280-25-026499

Chief Commercial Officer acquired 46,948 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Silvestro Stephen L Chief Commercial Officer 2025-05-15 Grant or award +46,948 168,262 D
Derivatives
Silvestro Stephen L Chief Commercial Officer 2025-05-15 Grant or award · Stock Option +80,884 80,884 D
Loading xslF345X05/wk-form4_1747685005.xml…